The TCGA database analysis further revealed that MAP3K8 expression was directly associated with stomach adenocarcinoma stage, with patients in stages 3, 2, and 4 of stomach cancer expressing more MAP3K8 compared to the patients in stage 1 of the disease and normal patients. The gene discussed is MAP3K8; the disease is gastric neoplasm.